AB
ATOS icon

Amalgamated Bank’s Atossa Therapeutics ATOS Stock Holding History

Amalgamated Bank’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-292
Closed -$3K – 3021
2025
Q1 		$3K Hold
292
– – ﹤0.01% 2767
2024
Q4 		$4K Hold
292
– – ﹤0.01% 2773
2024
Q3 		$7K Hold
292
– – ﹤0.01% 2596
2024
Q2 		$5K Buy
+292
New +$6.46K ﹤0.01% 2743
2022
Q2 		– Sell
-968
Closed -$18K – 3041
2022
Q1 		$18K Sell
968
-73
-7% -$1.48K ﹤0.01% 2830
2021
Q4 		$25K Sell
1,041
-33
-3% -$1.21K ﹤0.01% 2137
2021
Q3 		$53K Sell
1,074
-48
-4% -$2.79K ﹤0.01% 2126
2021
Q2 		$106K Buy
+1,122
New +$59.4K ﹤0.01% 2115

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Amalgamated Bank's ATOS Position: Q2 2025 in Review

Amalgamated Bank sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 292 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in ATOS in Q2 2021 and held it in 8 quarters. The position peaked at $106K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • Amalgamated Bank reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 292 Atossa Therapeutics shares in Q2 2025, an estimated $3K.
  • Amalgamated Bank first reported a position in Atossa Therapeutics in Q2 2021 and held it in 8 quarters.
  • Amalgamated Bank's Atossa Therapeutics position peaked at $106K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.